Laurence Turka

Laurence Turka

Corporate Officer/Principal bij
Immune Tolerance Network
68 jaar
Commercial Services
Health Technology
Consumer Services

Profiel

Laurence Turka is the founder of Rheos Medicines, Inc. which was founded in 2018.
He is currently the Deputy Director at Immune Tolerance Network.
He is also a Member of the Association of American Physicians since 2003 and a Member of the American Society for Clinical Investigation since 1995.
Dr. Turka has held several former positions including Chairman-Scientific Counselors at the National Institute of Allergy & Infectious Diseases, President at The American Society of Transplantation, Professor at Harvard Medical School, and Editor in Chief at The Journal of Clinical Investigation.
Dr. Turka received his doctorate degree from Yale School of Medicine.
Additionally, Dr. Turka was the Chief Scientific Officer & Head-Research at Rubius Therapeutics, Inc. from 2021 to 2023.

Actieve functies van Laurence Turka

BedrijvenFunctieBegin
Corporate Officer/Principal -
Corporate Officer/Principal 01-01-1995
Corporate Officer/Principal 01-01-2003

Eerdere bekende functies van Laurence Turka

BedrijvenFunctieEinde
RUBIUS THERAPEUTICS Hoofd Techniek/Wetenschap/O&O 31-01-2023
Oprichter 01-01-2020
Corporate Officer/Principal -
Corporate Officer/Principal -
President -
Ervaring van Laurence Turka in detail bekijken

Opleiding van Laurence Turka

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

49

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Commercial Services

Health Technology

Government

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Laurence Turka
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU